Tuttavia non è in grado di fornire risposte ad ogni domanda, né di risolvere qualsiasi situazione. Tuttavia, il membro di una famiglia non può supervisionare, né direttamente né indirettamente, un parente stretto, inclusi i parenti acquisiti, per via del potenziale e dell’apparente condizione di favoritismo. Non dovete copiare il software né installarlo su altri computer che violano i nostri accordi di licenza.

Social • Soutenir les droits fondamentaux de l’homme et ne pas avoir recours au travail forcé, au travail des enfants ou au travail provenant de la traite des êtres humains Les produits fournis à Avient ne doivent pas financer, ou soutenir directement ou indirectement des groupes armés en République démocratique du Congo ou dans un pays voisin (les « pays couverts », c’est-à-dire les pays limitrophes), et doivent respecter l’Énoncé de politique sur les minerais de conflit d’Avient concernant les produits fournis à Avient.

Common Types & Deniers T-430: Filament Yarn Deniers: 200, 1200, 1600, 2400

We are Avient. 4 B ET T E R TO G E TH E R : P O LYO NE A N D C L A R I A N T M A S T ER BATC H Key Data 2020 PF Sales (1) $3.7 billion 2020 PF EBITDA (1) $425 million ($500M w/synergies) Free Cash Flow $240 million (1) Estimated Pro forma for the acquisition of the Clariant Masterbatch business 87% of EBITDA from specialty applications U.S. & Canada 49% Europe 25% Asia 17% Latin America 9% SEGMENT, END MARKET AND GEOGRAPHY 5 GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 23% Packaging 21%Industrial 15% Wire & Cable 7% Building & Construction 6% Electrical & Electronics 4% END MARKET REVENUE Transportation 9% Healthcare 15% All data reflects 2020 estimate and Pro forma for acquisition of the Clariant Masterbatch business. (1) The total company sales and EBITDA of $3,650M and $425M, respectively, include intercompany sales eliminations and corporate costs $2,000M $310M $685M $115M $1,050M $65M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $425M$3,650M (1) Innovation is the lifeblood of a specialty company. PEER COMPARISONS 16 2 3 2 3 3 3 6 3 4 4 4 4 5 5 6 6 7 8 9 23 A vi e n t A vi e n t (E xc l. Such is the case with the Clariant Masterbatch acquisition, where strong free cash flow will allow us to de-lever quickly. 19 AV I E N T I S M O D E S T LY L EV ER ED 1.

Microsoft PowerPoint - AVNT Mar 2022 Presentation AVIENT CORPORATION I N V E S T O R M E E T I N G S (NYSE: AVNT) M A R C H 2 0 2 2 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 30 Capex / Revenue 2022E (%) AV I E N T I S A SS E T L I G H T Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 3 3 4 3 3 5 5 5 7 7 7 A vi e n t A vi e n t (E xc l. O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 5.4 8.5 10.1 10.0 15.7 15.0 14.2 12.7 10.2 25.0 19.7 17.7 13.2 12.3 10.0 9.9 8.9 8.5 8.3 6.6 A vi e n t (2 0 1 1 ) A vi e n t (2 0 1 6 ) A vi e n t (2 0 2 1 ) A vi e n t (T o d a y) R P M K W R P P G A V Y F U L A L B E C L H X L A S H F M C B N R E M N U N V R C E S C L H U N Historic Multiple S U M M A RY: W H Y I N V E S T I N AV I E N T ?

We are Avient. 4 B ET T E R TO G E TH E R : P O LYO NE A N D C L A R I A N T M A S T ER BATC H Key Financial Data (1) 2021E Sales $4.1 billion 2021E EBITDA $510 million 2021E Free Cash Flow $250 million 87% of EBITDA from specialty applications (1) As of February 9, 2021 webcast Innovation is the lifeblood of a specialty company. F U T U R E G ROW TH I N E XC E S S O F G D P I S D R I V E N B Y: Our company is positioned to sustainably grow at a rate that exceeds GDP. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 24 Capex / Revenue 2021E (%) AV I E N T I S A SS E T L I G H T Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 3 3 3 4 3 3 4 4 4 5 5 5 5 7 7 8 23 A vi e n t A vi e n t (E xc l.

Non raccogliamo né compiliamo i tuoi dati personali, fornitici come parte della tua domanda di assunzione, al fine di diffonderli o venderli a terzi per scopi di marketing. 5. Emendamenti e modifiche La presente Informativa non è, né intende essere, un'offerta di lavoro, né un contratto, né crea in altro modo alcun diritto o obbligo legale.

XBERGAMID B70 G30 H UV X1 BLACK T 70 XEDGETEK TX 30GF-000 H UV Balck T 70

Black t wisted HMPE yarn